BPC-157: reconstitution and dose ranges
bpc-157 dosage> Updated:
Calculate the BPC-157 dose
The calculator is already set up for BPC-157 — adjust the dose or diluent volume for your vial.
In short
There is no official BPC-157 regimen for humans: controlled human dosing studies do not exist. Protocols most often mention 250 mcg subcutaneously once daily at the start, 500 mcg/day in two injections in the extended regimen, and an upper bound near 800 mcg/day in 4–6 week cycles. These are reference points from descriptive practice, not proven doses.
Human dosing
| Period / condition | Dose | Escalation |
|---|---|---|
| Start | 250 mcg once daily, subcutaneous | Starting dose |
| Extended regimen | 500 mcg/day (125–250 mcg AM + PM) | Increase if needed |
| Upper bound (4–6 week cycle) | up to 800 mcg/day | Maximum in this schedule |
Practical dosage and effect notes
Controlled human dosing studies for BPC-157 are essentially absent: most dose-response data come from animal work, and the regimens on this page are drawn from research protocols and reconstitution practice, not from phase I–III clinical trials.
The split-dose logic (125–250 mcg AM and PM instead of 500 mcg in one shot) rests on pharmacological caution, not a measured human half-life: a short peptide in aqueous solution is unstable at room temperature, so smaller, more frequent doses reduce both concentration variability and how much of the reconstituted solution degrades between injections. The 800 mcg/day upper bound in this schedule is a reference point drawn from described protocols, not a proven effectiveness threshold.
This is reference information on regimens from published sources, not a medical recommendation.
Frequently asked questions
How many syringe units is 250 mcg? It depends on the reconstitution. Example: a 5 mg vial reconstituted with 2 ml of bacteriostatic water gives 2.5 mg/ml – then 250 mcg is 0.1 ml, or 10 units on a U-100 syringe. A different water volume means different units; the reconstitution calculator gives the exact figure.
Does the BPC-157 dose depend on body weight? In human protocols, no: ranges are given as fixed micrograms, not per kilogram. Weight-based calculation appears only in animal studies, and transferring it to humans is not valid.
Why split the dose into morning and evening? A short peptide in aqueous solution is unstable, and two smaller injections give a more even concentration: 125–250 mcg twice daily instead of 500 mcg in one shot. This is pharmacological caution, not a measured half-life.
How do I reconstitute a BPC-157 vial? With bacteriostatic water: slowly, down the wall of the vial, without shaking. The step-by-step technique is in the reconstitution guide.
How to reconstitute
An example reconstitution for convenient dosing. The exact ratios depend on your vial. For research reference only — not medical guidance.
- 1Add the diluentUse bacteriostatic water. Example: 2 ml into a 5 mg vial.BPC-1575 mg+ 2 mlDiluent
- 2Get the concentrationExample: 5 mg in 2 ml =BPC-1572.5 mg/ml(2,500 mcg/ml)
- 3Work out the volume per doseFor example, for a 0.25 mg dose:0.25 mg = 0.1 ml= 10 u. (U-100)
This is only an example calculation. You can use a different diluent volume — plug your own numbers into the calculator. Open calculator →
Research protocols
BPC-157: reference regimens
In described protocols BPC-157 is given by subcutaneous (SubQ) injection from a solution reconstituted with bacteriostatic water.
A search for BPC-157 dosing usually means one practical question: how many doses to split the daily amount into.
More scientific background in the BPC-157 monograph
Notes and safety
- • BPC-157 is a research peptide. Human safety and efficacy data are limited.
- • The regimens shown are based on publications and research protocols, not clinical recommendations.
- • Individual reactions may vary. Published protocols typically start dosing at the lower end of the reported range.
- • Not recommended for use with chronic illness, pregnancy, or breastfeeding.
- • This information is for educational purposes and is not medical advice.
